About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Treating Pulmonary Venous Hypertension
By
Scripps Health: 2019 Third Annual Clinical Advances in the Diagnosis and Management of Pulmonary Hypertension
FEATURING
Thomas Heywood
By
Scripps Health: 2019 Third Annual Clinical Advances in the Diagnosis and Management of Pulmonary Hypertension
FEATURING
Thomas Heywood
1,057 views
March 15, 2019
0 Comments
Login to view comments.
Click here to Login
Featured Video
18:06
Lilly Obesity
Getting Patients Started with an Obesity Treatment Option for Adults
Feat.
E. Lazarus
Related Content
AUTOPLAY
ON
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments
Primer on Diabetes Management
Feat.
S. Inzucchi
11:37
ACC 2022 Conference Coverage
ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…
Feat.
P. Heidenreich
11:25
ACC 2023 Conference Coverage
ACC 2023: SGLT2i Use - Dos and Don'ts
Feat.
A. Armbruster
31:46
ACC 2024 Insights
ACC 2024 Insights: Evolving Pharmacology for HFrEF vs. HFpFF - With …
Feat.
M. Costanzo
18:43
ASPC 2019 Congress on CVD Prevention
Diabetes Treatment Guidelines Finally Have Entered the 21st Century …
Feat.
R. DeFronzo
26:01
Cardiology Fiesta 2017
Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…
Feat.
R. DeFronzo
17:44
Rita Jermyn
SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease
27:24
Cardiometabolic Health Congress (CMHC)
SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes
Feat.
L. Sloan
14:19
UChicago Medicine
S-QUAD Therapy and Beyond: HFpEF in 2024
Feat.
M. Belkin
09:50
The Cardiogenic Shock Working Group
Hemodynamic vs. Hemo-Metabolic Shock: Redefining Shock Profiles
Feat.
N. Kapur
52:53
University of Colorado Department of Medicine
Interstitial Lung Disease in Rheumatic Diseases
Feat.
M. Griffith
19:30
ACC 2022 Conference Coverage
Hot Topics in Heart Failure ACC.22
Feat.
N. Ibrahim
17:36
Mount Sinai Advanced Innovations in Heart Failure
Contemporary Management of Cardiogenic Shock: Updates in 2022
Feat.
D. Baran
20:59
UChicago Medicine
Timing and Choice of Percutaneous Mechanical Circulatory Support (pM…
Feat.
S. Nathan
23:05
ACC 2023 Conference Coverage
ACC 2023: Mitral Regurgitation - Five Diagnostic and Therapeutic Cha…
Feat.
G. W. Stone
13:53
American Heart & Vascular Institute
Cardiogenic Shock: Should IABP or PVADs Be Used in Cardiogenic Shock?
Feat.
M. Ansari
10:02
Emory Diabetes Education Training Academy
Insulin Treatment in Patients with Type 2 Diabetes: When to Use Comb…
Feat.
G. Umpierrez
26:02
Mayo Clinic Pulmonary and Critical Care Educational Series
Right Heart Failure Secondary to Non-Group 1 PH
Feat.
H. Cajigas
13:42
George Bakris
Current Status of Prevention and Treatment of Diabetic Nephropathy
50:10
Gilbert Tang
Evolution in the Treatment of Valvular Heart Disease: From Surgery t…